KRT6A and myeloproliferative disorder: In addition, looking back to data obtained with the OncodriveCLUST algorithm, we found that KRT6A gene mutation was a highly prominent disease driver in MPN with an SC (Figure 4A), a phenomenon not observed in MPN control cases.